Arena Pharmaceuticals, Inc.
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed

News on Arena Pharmaceuticals, Inc.

... PR Newswire Arena Pharmaceuticals, Inc.(Nasdaq: ARNA) today announced the appointment of Manmeet S. Soni as a ...
... Teva · Roche · Orexigen/Takeda · Novo Nordisk · GlaxoSmithKline (GSK) · Eisai/Arena · This report discussesnovel mechanism of action, active pipeline molecules and promising ...
... SAN DIEGO - Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that members of its senior management team will ...
... has signed a licensing deal worth up to $1.2bn with biopharmaceutical firm Arena Pharmaceuticals for a hypertension drug candidate, ralinepag. Ralinepag is Arena's investigational, oral, ...
... Now wouldn't that be something! More on this later. INDICATIONS United Therapeutics, Arena rise on license agreement. Shares of United Therapeutics rose 5% while Arena ...
... PR Newswire Arena Pharmaceuticals, Inc.(Nasdaq: ARNA) andUnited Therapeutics Corporation(Nasdaq: UTHR) today announced that the companies have ...
... PR Newswire Arena Pharmaceuticals, Inc.(Nasdaq: ARNA) presented preclinical data for its recently announced investigational compound, APD418, ...
Subscribe now for full coverage on Arena Pharmaceuticals, Inc.
Start My Free Trial